(Q37230396)

19 August 2017

1 reference

title

Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease (English)

1 reference

19 August 2017

Pascal Meier

1 reference

19 August 2017

Rachel Meier

series ordinal

1 reference

19 August 2017

Edouard Blanc

series ordinal

1 reference

19 August 2017

publication date

1 August 2008

1 reference

Expert Review of Cardiovascular Therapy

19 August 2017

published in

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

page(s)

987-997

1 reference

Inflammation and cardiovascular risk in dialysis patients

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Oxidative cross-linking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood. Relevance to atherogenesis caused by hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Foxp3 and natural regulatory T cells: key to a cell lineage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Regulatory T cells in the control of immune pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

CD4+ Tregs and immune control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Natural regulatory T cells: mechanisms of suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Innate and acquired immunity in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Regulatory T-cell immunity and its relevance to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Immunomodulation of the inflammatory response in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Regulatory T-cell immunity in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Cytokines in atherosclerosis: pathogenic and regulatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Low leptin gene expression and hyperleptinemia in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Low serum leptin predicts mortality in patients with chronic kidney disease stage 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Impact of dyslipidemia in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

One-year immunological evaluation of chronic hemodialysis in end-stage renal disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

The Bcl-2 gene is differentially regulated by IL-2 and IL-4: role of the transcription factor NF-AT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Oxidized low-density lipoproteins activate CD4+ T cell apoptosis in patients with end-stage renal disease through Fas engagement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

Natural regulatory T cells control the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.7.987

21 January 2018

Identifiers

DOI

10.1586/14779072.6.7.987

1 reference

19 August 2017

1 reference